DripVitals is an online weight-loss clinic serving Reading, Pennsylvania — no storefront, no waiting room. Eligible Reading adults complete a secure intake, a licensed clinician reviews it, and if a GLP-1 medication like semaglutide or tirzepatide is appropriate, it ships from a licensed pharmacy to your door, with dose titration and follow-ups handled online.
It is an online, clinician-guided weight-management program for adults in the Reading area. Semaglutide is a GLP-1 receptor agonist that can help regulate appetite and blood sugar. After an online visit, a licensed clinician decides whether it is appropriate for you and, if so, sends a prescription to a partner pharmacy that ships to your door.
Depending on your clinical situation, your provider may prescribe an FDA-approved branded semaglutide (such as Wegovy or Ozempic) or, where appropriate, a compounded preparation from a licensed pharmacy. Compounded medications are not FDA-approved. Your clinician explains the options, and you see pricing before you confirm.
Timelines vary. In trials of FDA-approved branded semaglutide, weight change built gradually over many months alongside lifestyle changes. Semaglutide is not a quick fix; results depend on dose, adherence, diet, activity, and individual factors, and a clinician monitors your progress.

Lasting weight management is about steady metabolic health and habits you can keep — not a single number on the scale.
Semaglutide is a GLP-1 receptor agonist that helps regulate appetite and blood sugar, which can make a reduced-calorie plan easier to follow when it’s prescribed as part of clinician-supervised care. A licensed clinician reviews your history to decide whether it fits your situation.
It works best alongside the everyday basics — nutrition, movement, sleep, and follow-up — and and online check-ins make that consistency more realistic. Individual results vary.
Reading anchors Berks County along the Schuylkill, a historic city surrounded by Pennsylvania Dutch country, where specialty medical care often pulls patients toward the Lehigh Valley or Philadelphia.
DripVitals brings weight-loss care to Reading entirely online. You complete a secure intake, a licensed clinician reviews your history, and if a GLP-1 medication like semaglutide or tirzepatide is appropriate, a licensed pharmacy ships it to your door — with dose titration and follow-ups handled by message or video, and no Reading clinic to visit.
Every weight-loss journey is different, and so are our clinician-guided semaglutide plans for Reading members.

Complete your online intake
Share your health history and goals through a secure online form — no clinic visit needed.

Clinician evaluation
A licensed clinician reviews your information to determine whether semaglutide is appropriate for you.

Medication shipped to you
If prescribed, your medication ships from a licensed pharmacy to your Reading-area address, with supplies included.
Like any medication, semaglutide carries risks and is not appropriate for everyone. Reviewing the following with a licensed clinician is an essential part of treatment, and the FDA-approved labeling should be read in full.
FDA-approved semaglutide carries a boxed warning about the risk of thyroid C-cell tumors observed in rodents. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician about any such history.
Common effects can include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose increases. Serious risks reported with GLP-1 therapy include pancreatitis, gallbladder problems, low blood sugar (particularly alongside other diabetes medicines), kidney issues from dehydration, and allergic reactions. Seek prompt medical care for severe or persistent symptoms.
Semaglutide is generally not used during pregnancy or breastfeeding, in people with the thyroid or MEN 2 history above, with a history of pancreatitis, or with certain other conditions. Your clinician reviews your history and will decline treatment when it is not safe or appropriate. Not everyone who applies will qualify.
Share a complete list of your prescriptions, over-the-counter products, vitamins, and supplements so your clinician can check for interactions and adjust care as needed. Report side effects and health changes during follow-up. Individual results vary, and no specific outcome is guaranteed.
Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. A licensed provider determines whether a compounded medication is appropriate based on an individual patient’s medical needs.
DripVitals is an online clinic — there is no office to visit in Reading. A licensed clinician reviews your health history and, if a GLP-1 medication is appropriate, prescribes one of two options, shipped from a licensed pharmacy to your door:
The GLP-1 medication behind the brand names Wegovy and Ozempic, taken as a once-weekly injection — a well-established option for weight management. Plans from $199/month.
A dual GIP/GLP-1 medication — the active ingredient in Mounjaro and Zepbound — also a once-weekly injection, and in trials the more potent of the two. Plans from $129/month.
Which medication is right for you depends on your goals, medical history, and a licensed clinician’s assessment during your online visit. Both are prescribed only when appropriate.

A DripVitals semaglutide program is a clinician-guided subscription that bundles your care and medication into one plan — convenient for schedules that don’t leave much room for clinic visits. Depending on what your clinician prescribes, it typically includes:
Pricing depends on the plan you choose and what your clinician prescribes; branded and compounded options differ in price. There are no hidden fees, and you see exact pricing before you confirm.
| Plan | Price | Billing |
|---|---|---|
| Month-to-month | $179/mo | $179 billed monthly |
| 3-Month plan | $139/mo* | $417 billed every 3 months |
| 6-Month plan | $119/mo* | $714 billed every 6 months |
| 12-Month plan | $99/mo* | $1,188 billed every 12 months |
*The $199/month rate reflects a 6-month commitment paid upfront or through a buy-now-pay-later program. Actual price depends on the plan and medication prescribed, including whether a branded or compounded option is used. Plans are offered as a subscription that can be canceled at any time.
Major metros we serve online across Pennsylvania:
Care is delivered online throughout Pennsylvania wherever our clinicians are licensed. Weight-loss treatment in Pennsylvania · Our medical review team

This page was reviewed for medical accuracy. Treatment decisions are made by a licensed provider after reviewing each patient’s medical history.
Clear, medically reviewed answers about semaglutide for Reading members — how the online program works, branded vs compounded, safety, cost, and eligibility.
Semaglutide is a GLP-1 receptor agonist — it mimics a gut hormone that signals fullness, slows stomach emptying, and helps regulate blood sugar. It is the active ingredient in the FDA-approved medicines Wegovy and Ozempic. In large clinical trials of FDA-approved branded semaglutide, treatment alongside lifestyle changes produced meaningful average weight loss. Semaglutide is a prescription medication and is not appropriate for everyone.
It is an online, clinician-guided weight-management program available to adults in the Reading area and across Pennsylvania. DripVitals does not operate a walk-in clinic in Reading: you complete a secure online intake, a licensed clinician reviews it and (if appropriate) prescribes treatment, and a licensed pharmacy ships medication to your address. Your clinician monitors progress and adjusts care through follow-ups.
Depending on your clinical situation, your clinician may prescribe FDA-approved branded semaglutide (Wegovy or Ozempic) or, where appropriate, a compounded preparation from a licensed pharmacy. Compounded medications are not FDA-approved, and compounded semaglutide is not established as equivalent to the branded products. Your clinician explains the options and you see pricing before you confirm.
No. Compounded preparations are not reviewed or approved by the FDA for safety, effectiveness, or quality before they are marketed; a licensed pharmacy prepares them to fill an individual prescription. The active ingredient, semaglutide, is FDA-approved in branded products (Wegovy, Ozempic), but a compounded preparation is not itself an FDA-approved drug. Discuss the regulatory status, benefits, and risks with your clinician.
Start with a short online questionnaire and, if appropriate, a video or message-based visit with a licensed clinician. If they determine semaglutide is suitable for you, they send a prescription to a partner pharmacy that ships medication to you. If it is not appropriate, they will not issue a prescription.
Adults with obesity, or overweight with a weight-related condition, may be candidates when a clinician agrees the benefits outweigh the risks. It is not for everyone: personal and family medical history, current medications, and lab findings all factor into eligibility. Your clinician makes this determination during your consultation.
Semaglutide for weight management is typically a once-weekly subcutaneous injection using a small pen or syringe, started at a low dose and increased gradually (titrated) on a schedule your clinician sets. Your clinician and pharmacy materials explain injection sites, rotation, and storage. Oral formulations are also available in some cases.
Common effects can include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose increases. Serious risks reported with GLP-1 therapy include pancreatitis, gallbladder problems, and low blood sugar. FDA-approved semaglutide also carries a boxed warning about thyroid C-cell tumors and is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. Read the FDA-approved labeling and contact a clinician for severe or persistent symptoms.
No medication replaces nutrition, movement, sleep, and follow-up care. In trials of branded semaglutide, weight change built gradually over many months alongside lifestyle changes. GLP-1 therapy can support meaningful weight change for many people, but individual results vary and long-term success depends on adherence and medical oversight.
Monthly cost depends on your plan, dose, and whether a branded or compounded option is prescribed. Program pricing starts as low as $199/month on a 6-month plan paid upfront (or via buy-now-pay-later), with a month-to-month option at $299/month. You see exact pricing before you confirm, with no hidden fees, and you can cancel anytime.
The program is available to eligible adults in the Reading area and across Pennsylvania, wherever your clinician is licensed to provide care and a partner pharmacy can ship. Care is delivered entirely online, so you do not need to visit a physical Reading location.
No — DripVitals is telehealth-only, with no Reading storefront. Reading-area residents complete the visit online and receive medication by mail if a licensed clinician prescribes it.
Possibly. Share a complete list of everything you take — prescriptions, over-the-counter products, vitamins, and supplements — during your consultation. Semaglutide can affect how quickly the stomach empties and, alongside other diabetes medicines, can increase the risk of low blood sugar. Your clinician reviews your regimen and adjusts care as needed. Never start, stop, or change a medication without talking to a licensed clinician.
Only available if prescribed after an online consultation with a healthcare provider. Benefits outlined are based on third-party studies. Plans are offered as a subscription service which can be canceled at any time. Actual product packaging may appear differently than shown. Physicians may prescribe compounded medications as needed to meet patient requirements. The FDA does not review or approve any compounded medications for safety or effectiveness. The statements on this page have not been evaluated by the FDA. Results may vary. If you notice any side effects while using this treatment, contact your healthcare provider immediately.